Swiss National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $332M | Buy |
744,600
+42,000
| +6% | +$19.6M | 0.19% | 86 |
|
|
2025
Q4 | $319M | Sell |
702,600
-37,700
| -5% | -$16.2M | 0.19% | 87 |
|
|
2025
Q3 | $290M | Sell |
740,300
-38,000
| -5% | -$15.9M | 0.17% | 96 |
|
|
2025
Q2 | $346M | Buy |
778,300
+52,100
| +7% | +$24M | 0.21% | 83 |
|
|
2025
Q1 | $352M | Sell |
726,200
-3,000
| -0.4% | -$1.4M | 0.25% | 70 |
|
|
2024
Q4 | $294M | Sell |
729,200
-36,800
| -5% | -$17.1M | 0.2% | 82 |
|
|
2024
Q3 | $356M | Buy |
766,000
+1,200
| +0.2% | +$576K | 0.23% | 69 |
|
|
2024
Q2 | $358M | Sell |
764,800
-6,900
| -0.9% | -$2.99M | 0.25% | 70 |
|
|
2024
Q1 | $323M | Sell |
771,700
-35,400
| -4% | -$15M | 0.23% | 77 |
|
|
2023
Q4 | $328M | Sell |
807,100
-21,300
| -3% | -$7.87M | 0.24% | 74 |
|
|
2023
Q3 | $288M | Sell |
828,400
-101,900
| -11% | -$35.6M | 0.23% | 78 |
|
|
2023
Q2 | $327M | Sell |
930,300
-88,500
| -9% | -$29.8M | 0.22% | 79 |
|
|
2023
Q1 | $321M | Sell |
1,018,800
-23,600
| -2% | -$7.08M | 0.22% | 83 |
|
|
2022
Q4 | $301M | Sell |
1,042,400
-65,975
| -6% | -$20.1M | 0.22% | 92 |
|
|
2022
Q3 | $321M | Buy |
1,108,375
+4,100
| +0.4% | +$1.18M | 0.23% | 77 |
|
|
2022
Q2 | $311M | Buy |
1,104,275
+3,100
| +0.3% | +$830K | 0.21% | 86 |
|
|
2022
Q1 | $287M | Buy |
1,101,175
+115,100
| +12% | +$27.3M | 0.16% | 110 |
|
|
2021
Q4 | $217M | Sell |
986,075
-37,600
| -4% | -$7.31M | 0.13% | 132 |
|
|
2021
Q3 | $186M | Sell |
1,023,675
-36,300
| -3% | -$7.09M | 0.12% | 153 |
|
|
2021
Q2 | $214M | Sell |
1,059,975
-429,000
| -29% | -$89.7M | 0.13% | 139 |
|
|
2021
Q1 | $320M | Buy |
1,488,975
+21,500
| +1% | +$4.72M | 0.21% | 94 |
|
|
2020
Q4 | $347M | Buy |
1,467,475
+77,300
| +6% | +$17.7M | 0.25% | 74 |
|
|
2020
Q3 | $378M | Buy |
1,390,175
+204,400
| +17% | +$56.4M | 0.3% | 62 |
|
|
2020
Q2 | $344M | Buy |
1,185,775
+149,700
| +14% | +$40.6M | 0.29% | 66 |
|
|
2020
Q1 | $247M | Buy |
1,036,075
+205,900
| +25% | +$47.2M | 0.26% | 82 |
|
|
2019
Q4 | $182M | Sell |
830,175
-34,800
| -4% | -$7.04M | 0.19% | 101 |
|
|
2019
Q3 | $147M | Buy |
864,975
+10,866
| +1% | +$1.92M | 0.16% | 143 |
|
|
2019
Q2 | $157M | Buy |
854,109
+1,200
| +0.1% | +$210K | 0.17% | 123 |
|
|
2019
Q1 | $157M | Buy |
852,909
+22,000
| +3% | +$4.06M | 0.17% | 117 |
|
|
2018
Q4 | $138M | Buy |
830,909
+17,400
| +2% | +$3.01M | 0.18% | 118 |
|
|
2018
Q3 | $157M | Sell |
813,509
-25,300
| -3% | -$4.51M | 0.17% | 116 |
|
|
2018
Q2 | $143M | Buy |
838,809
+27,400
| +3% | +$4.25M | 0.16% | 133 |
|
|
2018
Q1 | $132M | Sell |
811,409
-117,600
| -13% | -$19.2M | 0.16% | 137 |
|
|
2017
Q4 | $139M | Buy |
929,009
+10,800
| +1% | +$1.6M | 0.15% | 152 |
|
|
2017
Q3 | $140M | Buy |
918,209
+11,100
| +1% | +$1.67M | 0.16% | 143 |
|
|
2017
Q2 | $117M | Buy |
907,109
+28,300
| +3% | +$3.41M | 0.14% | 159 |
|
|
2017
Q1 | $96.1M | Buy |
878,809
+189,000
| +27% | +$16.6M | 0.12% | 191 |
|
|
2016
Q4 | $50.8M | Buy |
689,809
+4,800
| +0.7% | +$391K | 0.08% | 270 |
|
|
2016
Q3 | $59.7M | Sell |
685,009
-5,600
| -0.8% | -$529K | 0.1% | 235 |
|
|
2016
Q2 | $59.4M | Buy |
690,609
+52,200
| +8% | +$4.51M | 0.1% | 236 |
|
|
2016
Q1 | $48.6M | Buy |
638,409
+193,900
| +44% | +$17.5M | 0.09% | 252 |
|
|
2015
Q4 | $55.9M | Buy |
444,509
+9,500
| +2% | +$1.15M | 0.14% | 169 |
|
|
2015
Q3 | $45.3M | Buy |
435,009
+44,700
| +11% | +$5.74M | 0.12% | 203 |
|
|
2015
Q2 | $48.2M | Buy |
390,309
+23,900
| +7% | +$3.01M | 0.12% | 196 |
|
|
2015
Q1 | $43.2M | Buy |
366,409
+145,100
| +66% | +$17.4M | 0.12% | 215 |
|
|
2014
Q4 | $26.3M | Sell |
221,309
-5,000
| -2% | -$563K | 0.1% | 224 |
|
|
2014
Q3 | $25.4M | Sell |
226,309
-3,500
| -2% | -$333K | 0.1% | 228 |
|
|
2014
Q2 | $21.8M | Buy |
229,809
+3,300
| +1% | +$231K | 0.08% | 261 |
|
|
2014
Q1 | $16M | Sell |
226,509
-21,600
| -9% | -$1.71M | 0.06% | 302 |
|
|
2013
Q4 | $18.4M | Sell |
248,109
-11,700
| -5% | -$815K | 0.07% | 277 |
|
|
2013
Q3 | $19.7M | Buy |
259,809
+27,600
| +12% | +$2.2M | 0.08% | 258 |
|
|
2013
Q2 | $18.5M | Buy |
+232,209
| New | +$17.1M | 0.08% | 262 |
|
Other funds holding VRTX
VCM
VPM
Swiss National Bank's VRTX Position: Q1 2026 in Review
Swiss National Bank increased its Vertex Pharmaceuticals (VRTX) stake by 6% in Q1 2026, buying an estimated $19.6M and bringing the position to 744,600 shares worth $332M. The position accounts for 0.19% of the portfolio, ranked #86.
Swiss National Bank first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $378M in Q3 2020. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Swiss National Bank held 744,600 shares of Vertex Pharmaceuticals worth $332M as of Q1 2026.
- Swiss National Bank bought 42,000 Vertex Pharmaceuticals shares in Q1 2026, an estimated $19.6M.
- Vertex Pharmaceuticals made up 0.19% of Swiss National Bank's portfolio in Q1 2026, its #86 holding.
- Swiss National Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Swiss National Bank's Vertex Pharmaceuticals position peaked at $378M in Q3 2020.
- 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.